RETRACTED: Case Report: Treatment of Hypertrophic Cardiomyopathy With Stereotactic Body Radiotherapy

Longzihui Xiao; Jiayi Liu; Yingzhe Zhang; Yuefei Liu; Yan Tang; Minping Zhang; Zhuyuan Ding; Enhua Xiao; Taili Chen

doi:10.3389/fmed.2022.799310

Frontiers in Medicine (Jun 2022)

RETRACTED: Case Report: Treatment of Hypertrophic Cardiomyopathy With Stereotactic Body Radiotherapy

Longzihui Xiao,
Jiayi Liu,
Yingzhe Zhang,
Yuefei Liu,
Yan Tang,
Minping Zhang,
Zhuyuan Ding,
Enhua Xiao,
Taili Chen

Affiliations

Longzihui Xiao: Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha, China
Jiayi Liu: Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, China
Yingzhe Zhang: Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha, China
Yuefei Liu: Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha, China
Yan Tang: Department of Medical Record, The Second Xiangya Hospital of Central South University, Changsha, China
Minping Zhang: Department of Ultrasound Diagnosis, The Second Xiangya Hospital of Central South University, Changsha, China
Zhuyuan Ding: Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, China
Enhua Xiao: Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, China
Taili Chen: Department of Oncology, Xiangya Hospital of Central South University, Changsha, China

DOI: https://doi.org/10.3389/fmed.2022.799310
Journal volume & issue: Vol. 9

Abstract

Read online

Patients with hypertrophic cardiomyopathy (HCM), which is characterized by left ventricular hypertrophy, is usually treated with medications such as calcium channel blockers or beta-blockers and invasive treatments such as transcatheter alcohol septal ablation, percutaneous radiofrequency ablation, or heart transplantation. However, non-invasive methods have not been employed for the management of patients with HCM. A 71-year-old male who presented with occasional chest pain for approximately 2 months and had been diagnosed with HCM since he was 39 years old due to occasional fainting was treated with a novel method for HCM using stereotactic body radiotherapy (SBRT). The administration of 25 Gy of radiation as one fraction led to an improvement in his quality of life. No toxicity occurred during or immediately after the treatment. Our observations suggest that SBRT may be a reasonable treatment approach for patients with HCM who are not suitable for surgery.

Published in Frontiers in Medicine

ISSN: 2296-858X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Medicine (General)
Website: http://www.frontiersin.org/journals/medicine

About the journal

Abstract

Keywords